[작성자:] UltraLog

A cancer diagnosis during pregnancy raises urgent and complex questions.

One of the most difficult is:

“Is radiation therapy safe during pregnancy?”

The answer depends on gestational age, radiation dose, and treatment location.

How Radiation Affects the Fetus

Radiation exposure risk depends on:

• Dose (measured in Gy or mGy)
• Gestational age
• Distance between treatment field and uterus

The fetus is most vulnerable during early organ development.

First Trimester: Highest Sensitivity

During weeks 2–12:

• Organogenesis occurs
• Risk of miscarriage increases
• Risk of congenital malformations rises

Radiation therapy is generally avoided in the first trimester whenever possible.

Second and Third Trimester: Risk Depends on Dose

After organ formation:

• Risk of structural malformations decreases
• Growth restriction and neurodevelopmental effects remain concerns at higher doses

If the radiation field is far from the uterus (e.g., brain tumors), fetal exposure may be minimal.

However, direct pelvic radiation is contraindicated during pregnancy.

Can Radiation Ever Be Considered?

Radiation therapy during pregnancy may be considered only if:

• The maternal condition is life-threatening
• Alternative treatments are not available
• Fetal exposure can be minimized with shielding and planning

Each case requires a multidisciplinary team including:

• Oncologists
• Obstetricians
• Medical physicists

Breast Cancer and Radiation

For pregnancy-associated breast cancer:

• Surgery is often performed during pregnancy
• Chemotherapy may be given in later trimesters
• Radiation therapy is usually postponed until after delivery

This approach minimizes fetal radiation exposure.

Fetal Radiation Exposure Risk

Estimated fetal risks depend on cumulative dose:

• <50 mGy → minimal measurable risk
• 100 mGy → increased concern for developmental effects
• Very high doses → risk of fetal loss or severe impairment

Modern radiation planning reduces scatter exposure significantly.

Counseling Perspective

Patients may assume all radiation equals severe harm.

It is important to clarify:

• Diagnostic ultrasound is safe
• Radiation risk depends on dose and location
• Many cancer treatments can be modified during pregnancy

Balancing maternal survival with fetal safety requires individualized planning.

Final Thoughts

Radiation therapy during pregnancy is generally avoided — especially in early gestation.

In rare, life-threatening situations, carefully planned treatment may be considered.

Multidisciplinary care ensures that both maternal and fetal risks are carefully evaluated.

A diagnosis of cancer during pregnancy raises one urgent question:

“Is chemotherapy safe during pregnancy?”

Balancing maternal treatment and fetal safety requires careful timing, multidisciplinary care, and evidence-based decision-making.

Can Chemotherapy Be Given During Pregnancy?

Yes — in selected cases.

Chemotherapy safety depends largely on gestational age.

First Trimester: High Risk Period

During the first trimester (weeks 1–12):

• Organ development occurs
• Risk of miscarriage increases
• Risk of congenital malformations is highest

Chemotherapy is generally avoided during the first trimester whenever possible.

Second and Third Trimester: Safer Window

Research shows that certain chemotherapy regimens can be administered more safely during:

• Second trimester
• Third trimester

Studies suggest:

• No significant increase in congenital malformations
• Slight risk of preterm birth
• Possible low birth weight

Long-term neurodevelopmental outcomes in many cases are reassuring.

Common Cancers Treated During Pregnancy

• Breast cancer
• Lymphoma
• Leukemia (selected cases)

Treatment plans are individualized based on cancer type and stage.

What About Delivery Timing?

Chemotherapy is usually stopped:

• 3–4 weeks before planned delivery

This reduces risks of maternal and neonatal complications related to bone marrow suppression.

Is the Baby Affected Long-Term?

Available follow-up studies suggest:

• Normal cognitive development in many children
• No consistent evidence of major developmental delay

However, long-term data are still evolving.

Close pediatric follow-up is recommended.

Counseling Perspective

Patients often fear that chemotherapy automatically harms the baby.

It is important to explain:

• Timing matters
• Multidisciplinary teams coordinate care
• Treatment decisions prioritize both maternal survival and fetal safety

Delaying necessary treatment can worsen maternal outcomes.

Evidence-based care allows many women to safely continue pregnancy while receiving cancer therapy.

Final Thoughts

Chemotherapy during pregnancy is not universally unsafe — but timing and regimen selection are critical.

Second and third trimester chemotherapy may be administered with careful monitoring.

Maternal health and fetal safety are not mutually exclusive goals when managed appropriately.

Pregnancy brings many changes to the breasts — enlargement, tenderness, and nodularity are common.

However, in rare cases, a persistent breast mass during pregnancy may represent pregnancy-associated breast cancer (PABC).

Early recognition is critical because physiological breast changes can delay diagnosis.

What Is Pregnancy-Associated Breast Cancer?

Pregnancy-associated breast cancer refers to breast cancer diagnosed:

• During pregnancy
• Within one year postpartum

Although uncommon, it is the most common cancer diagnosed during pregnancy.

Why Is Diagnosis Challenging?

Hormonal changes during pregnancy cause:

• Increased breast density
• Enlargement of glandular tissue
• Increased vascularity

These changes can mask early cancer signs on physical exam.

Patients and clinicians may attribute symptoms to normal pregnancy changes — leading to delayed evaluation.

Early Signs of Pregnancy-Associated Breast Cancer

The following symptoms should not be ignored:

🔎 Persistent Breast Mass

A lump that does not resolve after several weeks requires imaging evaluation.

🔎 Rapid Progressive Growth

Rapid enlargement unrelated to milk production may raise concern.

🔎 Irregular or Hard Texture

Non-mobile, firm masses warrant further investigation.

🔎 Skin Changes

• Dimpling
• Thickening
• Redness not consistent with mastitis

🔎 Nipple Changes

• Retraction
• Bloody discharge

🔎 Enlarged Axillary Lymph Nodes

Palpable lymph nodes may require ultrasound assessment.

Is Imaging Safe During Pregnancy?

Yes.

Breast ultrasound is the first-line imaging modality because it:

• Uses no radiation
• Differentiates cystic vs solid lesions
• Guides biopsy safely

Mammography with abdominal shielding may be considered if necessary.

Is Biopsy Safe During Pregnancy?

Core needle biopsy is generally safe during pregnancy and should not be delayed if imaging findings are suspicious.

Early diagnosis improves treatment options and outcomes.

Counseling Perspective

It is important to reassure patients:

• Most breast lumps during pregnancy are benign
• However, persistent or suspicious findings require evaluation
• Early imaging does not harm the baby

Balancing reassurance with vigilance is essential.

Final Thoughts

Pregnancy-associated breast cancer is rare but real.

A persistent breast mass during pregnancy should never be dismissed without proper imaging evaluation.

Early recognition and timely diagnosis protect both mother and baby.

Finding a breast mass during pregnancy can be frightening.

Hormonal changes cause significant breast enlargement and structural changes, making lumps more noticeable.

However, not all breast lumps during pregnancy are dangerous.

Understanding what is common and what requires evaluation helps reduce unnecessary anxiety.

Why Do Breast Lumps Appear During Pregnancy?

Pregnancy causes:

• Increased glandular tissue
• Milk duct proliferation
• Increased blood flow
• Breast enlargement

These changes can make pre-existing masses more noticeable or lead to new benign findings.

Common Causes of Breast Mass During Pregnancy

1️⃣ Fibroadenoma

• Hormone-sensitive
• May enlarge during pregnancy
• Typically oval and well-circumscribed on ultrasound

2️⃣ Lactating Adenoma

• Common in late pregnancy and breastfeeding
• Benign
• Often well-defined and hypervascular

3️⃣ Galactocele

• Milk-filled cyst
• Often occurs postpartum
• May show internal echoes on ultrasound

Can Breast Cancer Occur During Pregnancy?

Yes — although rare, pregnancy-associated breast cancer does occur.

Warning signs include:

• Irregular margins
• Rapid progressive growth
• Skin thickening
• Axillary lymphadenopathy

Persistent solid masses should not be ignored.

Is Ultrasound Safe During Pregnancy?

Yes.

Breast ultrasound is safe during pregnancy because it:

• Uses no radiation
• Provides detailed evaluation of solid vs cystic masses
• Guides biopsy when necessary

Mammography may be considered with shielding if clinically indicated.

When Is Biopsy Needed?

Biopsy is recommended if:

• Imaging features are suspicious
• The mass enlarges rapidly
• Clinical findings are concerning

Core needle biopsy is generally safe during pregnancy.

Early diagnosis is critical, even during pregnancy.

Counseling Perspective

Patients often assume:

“It’s pregnancy, so it must be hormonal.”

While many breast masses during pregnancy are benign, persistent or suspicious findings require evaluation.

Balanced reassurance with appropriate investigation is key.

Final Thoughts

A breast mass during pregnancy is common — but careful imaging evaluation is essential.

Most lesions are benign, but persistent or suspicious masses should be assessed promptly.

Pregnancy does not protect against breast cancer — early detection still matters.

Related Articles

Pregnancy-Associated Breast Cancer: Early Signs You Should Not Ignore

Is Chemotherapy Safe During Pregnancy? What Current Evidence Shows

Radiation Therapy During Pregnancy: Is It Ever Safe?

Discovering a rapidly growing breast mass can be alarming.

Many patients immediately fear cancer.

However, not all fast-growing breast lumps are malignant.

Understanding the causes, warning signs, and evaluation process is essential.

What Is Considered “Rapid Growth”?

A breast mass is considered rapidly growing when:

• Noticeable size increase occurs within weeks to months
• The lump becomes visibly larger between follow-up visits
• Growth exceeds 20% in 6 months on imaging

Documented interval growth is more important than subjective perception alone.

Common Causes of a Rapidly Growing Breast Mass

1️⃣ Fibroadenoma

• Common in younger women
• May enlarge due to hormonal stimulation
• Typically well-circumscribed and oval on ultrasound

Some fibroadenomas can grow quickly, especially during pregnancy.

2️⃣ Phyllodes Tumor

• Can grow rapidly
• Often larger at presentation (>3 cm)
• May show lobulated contour and heterogeneous echotexture

Phyllodes tumors require surgical excision due to recurrence risk.

3️⃣ Breast Cancer

Although less common than benign causes, malignancy must always be excluded.

Suspicious features include:

• Irregular margins
• Non-parallel orientation
• Posterior shadowing
• Increased internal vascularity
• Associated skin or nipple changes

Rapid growth combined with suspicious imaging findings increases concern.

When Is Biopsy Recommended?

Biopsy should be considered if:

• Rapid interval growth is confirmed
• Imaging features are atypical
• Patient is older than typical fibroadenoma age range
• Clinical concern persists despite benign appearance

Core needle biopsy provides tissue diagnosis and guides management.

Ultrasound Evaluation Matters

Ultrasound helps assess:

• Shape and margins
• Internal echo pattern
• Vascularity
• Relationship to surrounding tissue

Growth pattern over time is often more informative than a single scan.

Counseling Perspective

Hearing “rapidly growing breast mass” can cause intense anxiety.

It is important to explain:

• Many fast-growing masses are benign
• Imaging characteristics guide risk assessment
• Biopsy is performed when necessary for safety

Clear communication reduces panic while ensuring appropriate action.

Final Thoughts

A rapidly growing breast mass does not automatically mean cancer.

Careful imaging evaluation, interval comparison, and biopsy when indicated provide clarity.

Monitoring growth patterns — not just size — is key.

When a solid breast mass is detected on ultrasound, one of the most common questions is:

Is this a fibroadenoma or a phyllodes tumor?

Although both may appear similar, accurate differentiation is essential because management differs significantly.

What Is a Fibroadenoma?

Fibroadenoma is the most common benign solid breast tumor, especially in younger women.

Typical ultrasound features:

• Oval shape
• Circumscribed margins
• Parallel orientation
• Homogeneous hypoechoic texture
• Minimal internal vascularity

Most fibroadenomas are stable and may not require biopsy if classic features are present.

What Is a Phyllodes Tumor?

Phyllodes tumors are rare fibroepithelial tumors that can be:

• Benign
• Borderline
• Malignant

They tend to grow more rapidly and may require surgical excision.

Ultrasound Differences: Fibroadenoma vs Phyllodes Tumor

Although imaging overlap exists, certain features raise suspicion for phyllodes tumor:

🔎 Rapid Growth

Phyllodes tumors often enlarge quickly over months.

🔎 Larger Size

Lesions >3–4 cm raise suspicion, especially with interval growth.

🔎 Lobulated Contour

More pronounced lobulation compared to typical fibroadenoma.

🔎 Heterogeneous Internal Echo Pattern

Cystic spaces or clefts may be visible within the mass.

🔎 Increased Internal Vascularity

More prominent Doppler flow may be seen.

However, imaging alone cannot always definitively distinguish the two.

When Is Biopsy Recommended?

Biopsy should be considered when:

• Rapid size increase is documented
• Atypical imaging features are present
• Patient age is older than typical fibroadenoma population
• Clinical suspicion persists

Core needle biopsy helps guide management, but excision may still be recommended if phyllodes tumor is suspected.

Why Differentiation Matters

Fibroadenomas often require:

• Observation
• Periodic follow-up

Phyllodes tumors may require:

• Wide surgical excision
• Margin evaluation
• Close postoperative monitoring

Correct diagnosis impacts surgical planning and recurrence risk.

Counseling Perspective

When discussing a solid breast mass, clarity is important.

Instead of saying:

“It could be a tumor.”

Explain:

“Most solid masses in younger women are benign fibroadenomas. We monitor for stability. If the lesion shows rapid growth or atypical features, we recommend biopsy.”

Balanced counseling reduces unnecessary fear while ensuring timely action.

Final Thoughts

Fibroadenoma vs phyllodes tumor differentiation can be challenging on ultrasound.

Growth pattern, internal characteristics, and clinical context guide decision-making — but biopsy remains the definitive diagnostic tool when uncertainty exists.